The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Personally I always thought the HBE had the most potential. Selling nearly $1m in a day on QVC is impressive.
Improve the technology of the product and as the CEO says, this looks exciting.
It is suggested that Schlumberger are not on the rig. Using second rate outfits to do the wireline logging and perforating, to save money, can backfire.
Agree, particularly re JV, as the zinc asset is looking stronger with each RNS.
£3m market cap now looks mispriced.
Someone has confidence SP up 30% in a week.
Ransom ware or other hackers have caused severe disruption at the Guardian.
A warning to all businesses to get password protection software, at the least.
More power to OSI.
Perhaps better than expected. The water situation in India is not great, so there remains a chance of these machines catching on.
Results seemed ok, what am I missing?
Excellent trading update. A fast growing company with good management and high ambition.
Happy to hold here.
DP came across well. We are on track, and can look forward to regular updates on lab core sampling and further drilling results.
Our Mkt Cap is only £3m and considering the potential sizeable returns from the project, the firming up of data can only be excellent news for shareholders and the share price.
Looks to be very encouraging news.
Hbr , 50% gas production, cash flow benefitting, equally out slippage in oil price.
Share buyback continuing at pace.
Large hedge fund short position will need to be bought back.
News of compromise on WT will give a boost to SP.
W69, cheers. A critical few weeks then. Cash flow estimates for 2023 will hopefully be looking buoyant.
Gas prices are moving higher again today. Are we expecting our production to double upon a successful frack.
What are our high and low estimates for Southwark?
We will know within a week or two. Fingers crossed.
Ps it must be cold on that rig floor.